Indication
Chronic Lymphocytic Leukemia Transformation
1 clinical trial
3 products
Clinical trial
A Multi-Center, Open Label, Uncontrolled, Phase II Clinical Trial Evaluating the Safety and Efficacy of Venetoclax in Combination With Atezolizumab and Obinutuzumab in Richter Transformation of CLLStatus: Active (not recruiting), Estimated PCD: 2026-09-01
Product
ObinutuzumabProduct
AtezolizumabProduct
Venetoclax